← Back
$RVMD All transactions

Revolution Medicines, Inc.

▼ SELL 10b5-1 Plan

$ Value

$75K

Shares

1,878

Price

$40

Filed

Jun 18

Insider

Name

Cislini Jeff

Title

General Counsel

CIK

0001969082

Roles

Officer

Transaction Details

Transaction Date

2025-06-16

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

56,005

Footnotes

Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023. | This transaction was executed in multiple trades in prices ranging from $39.5915 to $39.8291, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. | Includes 160 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2025. | Includes 49,054 RSUs.

Filing Info

Accession No.

0001610717-25-000240

Form Type

4

Issuer CIK

0001628171

Cislini Jeff's History

Date Ticker Type Value
2025-09-24 RVMD $80K
2025-09-16 RVMD $86K
2025-06-20 RVMD $76K
2025-06-16 RVMD $75K

Other Insiders at RVMD (90d)

Insider Bought Sold Last
GOLDSMITH MARK A
See Remarks
$18.0M 2026-04-15
Mancini Anthony
See Remarks
$3.6M 2026-03-25